Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DEAD-box helicase 55 pseudogene 1 (DDX55P1) is a pseudogene related to the DEAD-box RNA helicase family, which are enzymes involved in diverse aspects of RNA metabolism, including RNA unwinding, splicing, and ribosome assembly[1][3]. However, unlike functional DEAD-box genes, DDX55P1 is classified as a pseudogene, meaning it does not code for an active protein product and has no known biological function or disease relevance. It is not recognized as a therapeutic target, nor are there any drugs, biomarkers, or safety considerations associated with it. Pseudogenes are regions of DNA that resemble functional genes but do not produce functional proteins due to disabling mutations or lack of regulatory elements[4]. The DEAD-box helicase family (e.g., DDX1, DDX5) includes many important RNA helicases with enzyme activity and roles in disease, but DDX55P1 is not among them because it is not a protein-coding gene[1][3]. There is no evidence of DDX55P1 contributing to pathology, drug action, or physiological processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEAD-box helicase 55 pseudogene 1 (DDX55P1).